Scottish National Investment Bank β 2024 Investments
4 investments dated 2024 Β· listed companies and verified rows first Β· show all
CALCIVIS develops the CALCIVIS Imaging System, a chairside diagnostic device that provides real-time assessment of enamel demineralization and tooth decay activity to support preventive dentistry.
BiotechDigital HealthHealthtechMedical DevicesEdinburgh, GB
Gregory M. Sheehan(CEO)inJill McGregor(COO)inBruce Vernon(Co-founder & CTO)Peter Anthony Rees(Director)Adam Christie(Co-founder & CEO)James Jonathan Browning(Director)
Co-investorsBritish Business BankMaven Capital PartnersScottish EnterpriseScottish Investment Bank
Cumulus Oncology is a drug development company specializing in oncology therapeutics, leveraging experienced leadership with track records in new drug applications and successful M&A transactions.
BiotechHealthtechLongevityMedical Devices
Catherine(CEO)Clare Wareing(CEO)in
Co-investorsAlba EquityApollo Informal InvestmentEos AdvisoryScottish Enterprise
EnteroBiotix is a clinical-stage microbiome therapeutics company developing EBX-102-02, an orally delivered, full-spectrum microbiome drug for irritable bowel syndrome and other gastrointestinal and liver diseases.
BiotechHealthtechGlasgow
James Roger McIlroy(Executive Officer, Director)Melissa Strange(Executive Officer)inJames Barnes(Executive Officer)in
BoardDouglas Campbell Thomson(Director)inFelix Andy Awili Olale(Director)Iain Baird(Director)
Co-investorsScottish Enterprise
iGii develops and manufactures Gii, a proprietary 3D porous pure carbon material for high-performance sensing, heating, and energy technologies.
Advanced ManufacturingCleantechDeep TechEnergyHardwareNew MaterialsScotland, GB
Dr. Marco Caffio(Co-founder & CSO)Jean-Christophe Granier(CEO & CCO)in
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.